# Eisai, Inc. – FDA Inspection, Apr 9, 2024

Source: https://www.keypedia.com/records/fda_inspections/eisai-inc/80e28e62-e45e-47a5-91af-86da4d269e63
Source feed: FDA_Inspections

> FDA inspection 1237510 of Eisai, Inc., April 09, 2024. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1237510
- Company Name: Eisai, Inc.
- Inspection Date: 2024-04-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1335274 - 2026-09-15](https://www.keypedia.com/records/fda_inspections/eisai-inc/21cba403-4bda-47f1-b50e-b846dfd35feb)
- [FDA Inspection 977950 - 2016-07-22](https://www.keypedia.com/records/fda_inspections/eisai-inc/f87debb9-7631-4271-a132-acdd054f27d1)
- [FDA Inspection 860646 - 2013-12-17](https://www.keypedia.com/records/fda_inspections/eisai-inc/275f72a8-1c6c-46af-80a4-48b53643953e)
- FDA Inspection 722050 - 2011-05-09
- FDA Inspection 669338 - 2010-05-12

## Related Officers

- [Azeezat M. Lawal](https://www.keypedia.com/people/azeezat-m-lawal/6068345c-a8c8-438e-9b59-f7fc35370a59)
- [Company Rep](https://www.keypedia.com/people/catherine-o-lamptey/9ddfa564-70b7-4a8b-9209-9d21205ebf60)
- [FDA Associated Person](https://www.keypedia.com/people/pushpa-s-jayasekara/cfd7d22f-b4c2-4002-ae18-b5435815d27d)
- [Yaharn Su](https://www.keypedia.com/people/yaharn-su/75b7f7fd-d853-436e-b538-386a8c6df3cb)

Company: https://www.keypedia.com/companies/eisai-inc/1e0d6af4-f962-4ac0-826f-90ce5f71a0a3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
